{"title":"Pharmacy: a history of science and conscience.","authors":"Rita de la Plaza","doi":"10.33620/FC.2173-9218.2026.29","DOIUrl":"https://doi.org/10.33620/FC.2173-9218.2026.29","url":null,"abstract":"<p><p>The history of Pharmacy is, to a large extent, the history of our relationship with disease, with medicines and with science itself. It is a history built over centuries which, for the first time, is now being opened up to the whole population through a public exhibition that traces the evolution of the pharmacy profession from its origins to the present day.</p>","PeriodicalId":40648,"journal":{"name":"Farmaceuticos Comunitarios","volume":"18 4","pages":"e340"},"PeriodicalIF":0.7,"publicationDate":"2026-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13670048/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149240105","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Farmaceuticos ComunitariosPub Date : 2026-10-12eCollection Date: 2026-10-15DOI: 10.33620/FC.2173-9218.2026.36
Elena Bethencourt-Barbuzano, Soraya Paz-Montelongo, Ángel José Gutiérrez, Arturo Hardisson de la Torre, Montaña Cámara Hurtado, Carmen Rubio Armendáriz
{"title":"Consumption and knowledge of protein supplements in the Spanish adult population: A cross-sectional survey-based study.","authors":"Elena Bethencourt-Barbuzano, Soraya Paz-Montelongo, Ángel José Gutiérrez, Arturo Hardisson de la Torre, Montaña Cámara Hurtado, Carmen Rubio Armendáriz","doi":"10.33620/FC.2173-9218.2026.36","DOIUrl":"10.33620/FC.2173-9218.2026.36","url":null,"abstract":"<p><strong>Introduction: </strong>The popularity of protein supplements (PS) has increased significantly in recent years. Their use is often undertaken without the supervision of a healthcare professional, which may lead to excessive or inappropriate intake and, consequently, pose a health risk.</p><p><strong>Objective: </strong>To assess knowledge and consumption habits regarding PS among the Spanish population.</p><p><strong>Material and methods: </strong>A cross-sectional observational study was conducted using a digital questionnaire (Google Forms®) among 168 participants aged 15-70 years.</p><p><strong>Results: </strong>Overall, 35.7% of respondents reported consuming PS, with increasing muscle mass being the main reason for consumption among 66.7% of these participants. Although 100% of participants recognised the risks associated with excessive consumption, 26.2% were unaware of the existence of maximum recommended intakes. Among those who were aware of these limits, most believed that the maximum intake was above 30 g of PS per day.</p><p><strong>Discussion: </strong>There is a substantial gap between PS consumption and knowledge of safe intake levels. These findings highlight the need to strengthen the role of community pharmacists as key healthcare professionals in promoting the rational and safe use of PS.</p>","PeriodicalId":40648,"journal":{"name":"Farmaceuticos Comunitarios","volume":"18 4","pages":"e285"},"PeriodicalIF":0.7,"publicationDate":"2026-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13655811/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149240081","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Social Marketing Strategies in the Pharmaceutical Industry, Characteristics and Impact; a scoping review.","authors":"Ludwing Bernart Carreño-Patiño, Estefany Isabel Menco-Goenaga, Rubén Darío Cepeda-Obregón","doi":"10.33620/FC.2173-9218.2026.33","DOIUrl":"10.33620/FC.2173-9218.2026.33","url":null,"abstract":"<p><strong>Objective: </strong>To describe the social marketing strategies implemented by the pharmaceutical industry and their potential impact on consumer behavior and access to medicines, through a scoping review.</p><p><strong>Methods: </strong>A scoping review was conducted following the PRISMA-ScR guidelines. For data collection, scientific articles published between 2006 and 2025 in English and Spanish were selected using the PCC criteria (Population, Concept, Context), which are recommended for this type of research. The databases consulted were SciELO, Google Scholar, and PubMed. Articles published in peer-reviewed academic journals were included if their title, abstract, or keywords contained at least one of the descriptors used in the search equation.</p><p><strong>Results: </strong>Four categories of analysis emerged: 1) marketing and positioning, 2) corporate social responsibility, communication, and ethics, 3) digital transformation and innovation, and 4) pharmacy and access to medicines. A critical inflection point was identified, highlighting the intersection of access to medicines with the role of community pharmacies, which are implementing strategies to balance social commitments with commercial objectives.</p><p><strong>Conclusions: </strong>The pharmaceutical industry's social marketing strategies can be multidimensional. They have evolved from traditional corporate positioning to emerging categories that integrate ethics, digital transformation, and public health innovation. The current challenge lies in balancing business viability with the population's health and social needs.</p>","PeriodicalId":40648,"journal":{"name":"Farmaceuticos Comunitarios","volume":"18 4","pages":"e273"},"PeriodicalIF":0.7,"publicationDate":"2026-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13654083/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149240071","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Farmaceuticos ComunitariosPub Date : 2026-10-04eCollection Date: 2026-10-15DOI: 10.33620/FC.2173-9218.2026.34
Damià Barris-Blundell, Gema Benítez-Pacheco, Miguel Ángel Mercado-Cano, María José Hidalgo-Hidalgo, Afrah Ismaiel-Bani Almarjeh
{"title":"Comparative analysis of quality indicators in two ISO 9001:2015-certified community pharmacies (2020-2025).","authors":"Damià Barris-Blundell, Gema Benítez-Pacheco, Miguel Ángel Mercado-Cano, María José Hidalgo-Hidalgo, Afrah Ismaiel-Bani Almarjeh","doi":"10.33620/FC.2173-9218.2026.34","DOIUrl":"10.33620/FC.2173-9218.2026.34","url":null,"abstract":"<p><strong>Objective: </strong>To comparatively analyse the results of selected quality indicators from the quality management system certified in accordance with ISO 9001:2015 in two community pharmacies during the period 2020-2025.</p><p><strong>Methods: </strong>A retrospective comparative study was conducted in two community pharmacies certified according to ISO 9001:2015. The following indicators were analysed: dispensing errors, complaints, recorded pharmaceutical interventions, follow-up of new medical prescriptions, adverse drug reactions (ADRs) reported to the Andalusian Pharmacovigilance Centre, negative outcomes associated with medication (NOMs) detected, ambulatory blood pressure monitoring (ABPM), and documented referrals to physicians. Dispensing errors and complaints were assessed quarterly and compared using paired-sample tests. The remaining indicators were analysed annually using count regression models adjusted for year and number of operations.</p><p><strong>Results: </strong>Statistically significant differences were observed in five of the eight indicators analysed. Pharmacy B showed higher values for complaints and reported ADRs, whereas Pharmacy A showed higher values for detected NOMs, ABPM, and recorded pharmaceutical interventions. No significant differences were observed between the two pharmacies in dispensing errors, documented referrals to physicians, or follow-up of new medical prescriptions.</p><p><strong>Conclusions: </strong>Quality indicators made it possible to identify variability between two ISO 9001:2015-certified community pharmacies and proved useful in supporting continuous improvement processes. The interpretation of the observed differences should take into account the contextual, organisational and healthcare-related characteristics of each pharmacy. Comparison between pharmacies remains limited by the absence of a common framework of validated indicators and reference standards in community pharmacy.</p>","PeriodicalId":40648,"journal":{"name":"Farmaceuticos Comunitarios","volume":"18 4","pages":"e302"},"PeriodicalIF":0.7,"publicationDate":"2026-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13643004/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149239998","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"From voluntary efforts to established procedures: the communication our patients need.","authors":"Vicente Javier Baixauli Fernández","doi":"10.33620/FC.2173-9218.2026.28","DOIUrl":"10.33620/FC.2173-9218.2026.28","url":null,"abstract":"<p><p>Coordination between primary care physicians and community pharmacists remains an unresolved issue within the Spanish National Health System. This editorial reviews the evolution of the proposals promoted by SEMERGEN and SEFAC to establish bidirectional communication channels between these two professional groups. It also examines initiatives developed in different autonomous communities and argues for the need to transform a longstanding demand into an integrated care procedure. Improving this communication would represent progress in continuity of care, patient safety, and healthcare system efficiency.</p>","PeriodicalId":40648,"journal":{"name":"Farmaceuticos Comunitarios","volume":"18 3","pages":"e254"},"PeriodicalIF":0.7,"publicationDate":"2026-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13383676/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148550745","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Farmaceuticos ComunitariosPub Date : 2026-07-10eCollection Date: 2026-07-15DOI: 10.33620/FC.2173-9218.2026.26
Roberto Lozano, Carina Bona
{"title":"Clinical relevance of cytochrome P450-mediated drug-drug interactions in hospitalised older adults: implications for community pharmacy.","authors":"Roberto Lozano, Carina Bona","doi":"10.33620/FC.2173-9218.2026.26","DOIUrl":"10.33620/FC.2173-9218.2026.26","url":null,"abstract":"<p><p>Cytochrome P450 (CYP)-mediated drug-drug interactions constitute a relevant safety issue in hospitalised older patients, due to multimorbidity and polypharmacy. The objective was to characterise these interactions and analyse the factors associated with their occurrence. A retrospective observational study was conducted in a cohort of patients aged ≥ 65 years admitted between 2020 and 2023. Data from the electronic prescribing system were analysed using descriptive statistics, bivariate analysis and multivariate logistic regression, evaluating the association between clinically relevant interactions and clinical and demographic variables. CYP3A4 was the most frequently involved isoenzyme, followed by CYP2C19 and CYP2D6. Although the total number of interactions was high, only a proportion was considered clinically relevant. In the multivariate analysis, polypharmacy was independently associated with the presence of interactions, whereas age, sex, Charlson index and admission diagnosis showed no significant association. These results highlight the need for pharmacist-led medication reconciliation and coordinated deprescribing strategies between hospital and community pharmacy, emphasising the role of the latter in detecting clinically relevant interactions, especially during care transitions after hospital discharge.</p>","PeriodicalId":40648,"journal":{"name":"Farmaceuticos Comunitarios","volume":"18 3","pages":"e256"},"PeriodicalIF":0.7,"publicationDate":"2026-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13356572/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148550698","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Farmaceuticos ComunitariosPub Date : 2026-07-10eCollection Date: 2026-07-15DOI: 10.33620/FC.2173-9218.2026.27
Andrea Rodríguez Esquíroz, Patricia García González, Arantza Viamonte Ezcurdia, Marta Marín Marín, Amaya Echeverría Gorriti, Ana Otamendi Murillo, Marta Galipienzo Jimenez
{"title":"Improving patient care: communication channel between health centres and community pharmacies through the electronic prescribing application.","authors":"Andrea Rodríguez Esquíroz, Patricia García González, Arantza Viamonte Ezcurdia, Marta Marín Marín, Amaya Echeverría Gorriti, Ana Otamendi Murillo, Marta Galipienzo Jimenez","doi":"10.33620/FC.2173-9218.2026.27","DOIUrl":"10.33620/FC.2173-9218.2026.27","url":null,"abstract":"<p><p><b>Introduction:</b>Navarra´s healthcare model is based on coordination between healthcare levels and the integration of diverse healthcare professionals across them. The objectives of this study were describe the design, implementation, and evaluation a communication channel between Primary Care (PC) teams and Community Pharmacies (CP) within each Basic Health Zone in Navarra, integrated into the electronic prescription system. <b>Materials and Methods:</b> A channel was designed to enable interaction between CP and PC professionals through the electronic prescription. A procedure was developed, outlining responsibilities, notification protocols and the distinction between urgent and non-urgent incidents. For the evaluation, a satisfaction survey was distributed to all participants. <b>Results:</b> The system was progressively expanded since 2021, reaching 95% of PC teams and 100% of CPs in 2024. Satisfaction surveys revealed a high appraisal of the channel, particularly among CPs, highlighting its utility, improvements in work organization and optimization of resolution times. <b>Conclusion:</b> The implementation of an appropriate communication channel between PC teams and CPs is essential for enhancing patient care. This channel has improved the quality of interprofessional collaboration, acting as a catalyst for alignment and trust between HC and CP professionals.</p>","PeriodicalId":40648,"journal":{"name":"Farmaceuticos Comunitarios","volume":"18 3","pages":"e266"},"PeriodicalIF":0.7,"publicationDate":"2026-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13356573/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148550715","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Farmaceuticos ComunitariosPub Date : 2026-06-25eCollection Date: 2026-07-15DOI: 10.33620/FC.2173-9218.2026.25
C Díaz López
{"title":"Debunking Constipation Myths: What Community Pharmacists Need to Know.","authors":"C Díaz López","doi":"10.33620/FC.2173-9218.2026.25","DOIUrl":"10.33620/FC.2173-9218.2026.25","url":null,"abstract":"<p><p>Constipation is a highly prevalent gastrointestinal disorder that significantly impacts quality of life and is associated with a substantial healthcare burden. Despite advances in its clinical understanding, its management remains hindered by the persistence of myths and unfounded beliefs that compromise appropriate treatment and obstruct effective healthcare intervention. This study aims to identify, analyze, and clarify some of the most frequent misconceptions surrounding constipation, providing community pharmacists with an evidence-based tool to enhance their clinical and educational practice. A narrative review of the scientific literature published between 2015 and 2025 was conducted, drawing from biomedical databases (PubMed, ScienceDirect, Cochrane) and institutional sources. Selected materials included articles, clinical guidelines, and consensus documents focused on myths related to the pathophysiology, treatment, and prevention of constipation. Among the most prevalent misconceptions are: the necessity of daily bowel movements, the effectiveness of increased fluid intake or olive oil on an empty stomach, the alleged harmfulness or addictive potential of laxatives, the belief that affects only women, and its supposed direct link to colorectal cancer. Misunderstandings regarding the role of dietary fiber, probiotics, and specific foods were also explored. The findings reveal a significant discrepancy between popular beliefs and current scientific knowledge. It is concluded that community pharmacists, as first-line healthcare providers, must play an active role in dispelling misconceptions about constipation through rigorous, evidence-based, and personalized patient education.</p>","PeriodicalId":40648,"journal":{"name":"Farmaceuticos Comunitarios","volume":"18 3","pages":"e209"},"PeriodicalIF":0.7,"publicationDate":"2026-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13310362/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148362929","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Farmaceuticos ComunitariosPub Date : 2026-06-17eCollection Date: 2026-07-15DOI: 10.33620/FC.2173-9218.2026.24
A Vera Peña, S Dévora Gutiérrez, C Morales Marrero, I Vitória Figueiredo, R Sicilia González, S Abdala Kuri
{"title":"Pharmacotherapeutic Optimization in a Polymedicated Patient Through Coordinated Pharmaceutical Intervention: A Community Pharmacy Case Report.","authors":"A Vera Peña, S Dévora Gutiérrez, C Morales Marrero, I Vitória Figueiredo, R Sicilia González, S Abdala Kuri","doi":"10.33620/FC.2173-9218.2026.24","DOIUrl":"10.33620/FC.2173-9218.2026.24","url":null,"abstract":"<p><p><b>Case presentation:</b> An 82-year-old woman, polymedicated (receiving chronic treatment with ten active pharmaceutical ingredients) and independent for basic activities of daily living, was evaluated. Following a hospital consultation due to fatigue and electrolyte disturbances, a family member attended the community pharmacy (CP) with the clinical documentation, requesting support to improve adherence and pharmacotherapy follow-up through repackaging using a Multicompartment Compliance Aid (MCA) [1]. <b>Case study and evaluation:</b> During the initial interview, several Drug-Related Problems (DRPs) were identified: inappropriate dosage of olmesartan/hydrochlorothiazide, combination of diuretics with kaliuretic effect (torasemide and hydrochlorothiazide), prolonged use of omeprazole without current indication, lack of recent laboratory monitoring in the management of hypercholesterolemia, untreated cognitive impairment, and unnecessary prescription of paracetamol. These DRPs posed a risk of generating Negative Outcomes associated with Medication (NOMs) within the three categories established by the Community Pharmacy Pharmaceutical Care Forum: necessity, effectiveness, and safety (2). <b>Intervention:</b> From the community pharmacy, and in coordination with the family and the primary care team, the dosage regimen of olmesartan/hydrochlorothiazide was adjusted, torasemide and paracetamol were discontinued, the atorvastatin dose was modified according to recent laboratory results, and, following specialist recommendation, memantine 10 mg/day together with cognitive stimulation measures was initiated. <b>Results:</b> Serum potassium levels normalized, adequate blood pressure control was achieved, the lipid profile was optimized, and therapeutic adherence improved through the use of the MCA. The patient reported better sleep quality, absence of pain, and greater functional autonomy. <b>Conclusions:</b> Coordinated intervention between community pharmacy, family environment, and primary care allowed optimization of pharmacotherapy, reduction of overmedication, and improvement in quality of life. This case illustrates the clinical and social value of Professional Pharmaceutical Care Services when developed within an integrated care framework, reinforcing the strategic role of community pharmacy in the comprehensive care of older polymedicated patients within a person-centered healthcare model.</p>","PeriodicalId":40648,"journal":{"name":"Farmaceuticos Comunitarios","volume":"18 3","pages":"e253"},"PeriodicalIF":0.7,"publicationDate":"2026-06-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13274723/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148362980","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Farmaceuticos ComunitariosPub Date : 2026-06-03eCollection Date: 2026-07-15DOI: 10.33620/FC.2173-9218.2026.23
S Nadal Domingo, S Mir Palomo, D Domingo Tortajada
{"title":"Management of Nocturnal Hypoglycaemia in a Patient with Type 2 Diabetes: The Role of Community Pharmacy.","authors":"S Nadal Domingo, S Mir Palomo, D Domingo Tortajada","doi":"10.33620/FC.2173-9218.2026.23","DOIUrl":"10.33620/FC.2173-9218.2026.23","url":null,"abstract":"<p><p>62-year-old woman with type 2 diabetes mellitus (T2DM) and chronic kidney disease presented to the community pharmacy due to episodes of nocturnal hypoglycemia. Interventions were carried out including diabetes education, adjustment of the insulin regimen, and personalized dietary recommendations, which eliminated the hypoglycemic episodes, improved glycemic control, and enhanced the patient's quality of life. This case highlights the key role of community pharmacy in detecting and resolving medication-related problems in chronic patients.</p>","PeriodicalId":40648,"journal":{"name":"Farmaceuticos Comunitarios","volume":"18 3","pages":"e234"},"PeriodicalIF":0.7,"publicationDate":"2026-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13231406/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148266569","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}